www.neurologiepropraxi.cz / Neurol. praxi. 2023;24(3):168-179 / NEUROLOGIE PRO PRAXI 179 HLAVNÍ TÉMA Autoimunitní encefalitidy 20. Thaler FS, Zimmermann L, Kammermeier S, et al. Rituximab Treatment and Long‑term Outcome of Patients With Autoimmune Encephalitis: Real‑world Evidence From the GENERATE Registry. Neurol Neuroimmunol Neuroinflamm. 2021;8:e1088. 21. Saiz A, Blanco Y, Sabater L, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain. 2008;131:2553-63. 10. 1093/brain/awn183. 22. Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58(4): 512-21. 23. Steriade C, Britton J, Dale RC, et al. Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune‐associated epilepsy: Conceptual definitions. Epilepsia. 2020;61(7):1341-51. 24. Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect, DiS. 2013;57(8):1114-28. 5. NEURO MUSKULÁRNÍ FÓRUM 21.–22. 9. 2023 Hotel Kraskov Třemošnice-Starý Dvůr VÍCE INFORMACÍ NA www.kongresneurologie.cz
RkJQdWJsaXNoZXIy NDA4Mjc=